Proton Magnetic Resonance Spectroscopy of the Striatum in Parkinson's Disease Patients with Motor Response Fluctuations

Parkinsonism and Related Disorders

Volumn 2, Issue 2, 1996, Pages 63-67

  Chaudhuri, K Ray ^a   Lemmens, G M ^a   Williams, S C R ^a   Ellis, C ^a   Lloyd, C M ^a   Dawson, J ^a   Simmons, A ^a   Leigh, P N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Magnetic resonance spectroscopy; Parkinson's disease; Putamen

Indexed keywords

EID: 0002838074     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/1353-8020(96)00007-7     Document Type: Article

References (19)

1. Lees AJ. The on-off phenomenon. J. Neurol. Neurosurg. Psychiatry 1989; Suppl: 29-37.
2. Brooks DJ. Functional imaging in relation to parkinsonian syndromes. J. Neurol. Sci. 1993; 115: 1-17.
3. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J. Neurology 1994; 241: 354-371.
4. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neuroscience 1993; 13: 981-989.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992; 55: 181-184.
6. Ordidge RJ, Bendall MR, Gordon RE, Connoly A. Volume selection for in-vivo biological spectroscopy. In: Govil G, Khetrapal, Savan, eds. Magnetic Resonance in Biology and Medicine. New Dehli: McGraw-Hill; 1985: 387-397.
7. Bottomley PA. Spatial localisation in NMR-spectroscopy in vivo. Ann. NY Acad. Sci. 1987; 508: 333-348.
8. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N. Engl. J. Med. 1988; 318: 876-880.
9. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterisation of plaques in multiple sclerosis. Neurology 1991; 41: 1251-1256.
10. Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic and MR imaging findings. Radiology 1993; 188: 119-124.
11. Arnold DL. Reversible reduction of N-acetylaspartate after acute central nervous system damage. In: Proceedings of the Eleventh Annual Meeting of the Society for Magnetic Resonance in Medicine, Vol. 1, 1992: 643..
12. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
13. Riederer P, Wuketich ST. Time course of nigrostriatal degeneration in Parkinson's disease. J. Neural Transmiss. 1976; 38: 277-301.
14. Davie CA, Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N, McDonald WI, Marsden CD, Miller DH. Differentiation of multiple system atrophy from Idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann. Neurology 1995; 37: 204-210.
15. Holshouser BA, Komu M, Moller HE, Zijlmans J, Kolem H, Hishaw Jr DB, et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: A multicentre pilot study. Magn. Res. Med. 1995; 33: 589-594.
16. Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov. Disord. 1990; 5: 100-108.
17. Lach B, Grimes D, Benoit B, Minkiewicz JA. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. Acta Neuropathol. Berl. 1992; 83: 352-360.
18. Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J. Neurol. Sci. 1973; 20: 415-455.
19. Gnanalingham KK, Robertson RG. Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6- hydroxydopamine lesioned rats- an autoradiographic study using [3H]flunitrazepam. Neuroscience 1993; 57: 673-681.